<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01468662</url>
  </required_header>
  <id_info>
    <org_study_id>Study 1569</org_study_id>
    <nct_id>NCT01468662</nct_id>
  </id_info>
  <brief_title>CMR Repeatability in STEMI</brief_title>
  <official_title>Cardiovascular Magnetic Resonance Scan Repeatability in ST Segment Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bristol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bristol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to conduct a study to measure the reproducibility of CMR parameters&#xD;
      that have been used to predict outcome following PPCI: infarct size, left ventricular&#xD;
      volumes, myocardial salvage, microvascular obstruction (MVO) and myocardial oedema.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inter-observer, intra-observer and inter-scan variability and agreement</measure>
    <time_frame>Between 2 scans</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>STEMI</condition>
  <arm_group>
    <arm_group_label>STEMI</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        ST segment elevation myocardial infarction&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participant may enter study if ALL of the following apply&#xD;
&#xD;
          1. ST segment myocardial infarction as defined by ECG (by 2 contiguous limb leads with &gt;1&#xD;
             mm ST-segment elevation, or &gt;2 mm ST-segment elevation in contiguous precordial leads,&#xD;
             or new LBBB) and &gt; 20 minutes of cardiac chest pain&#xD;
&#xD;
          2. Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Participant may not enter study if ANY of the following apply&#xD;
&#xD;
          1. Contraindication to MRI (implanted pacemaker/ defibrillator, ferromagnetic metal&#xD;
             implant/ injury, claustrophobia, obesity/ too large for CMR scanner)&#xD;
&#xD;
          2. Known allergy to gadolinium&#xD;
&#xD;
          3. Chronic atrial fibrillation&#xD;
&#xD;
          4. Renal impairment with eGFR &lt;30&#xD;
&#xD;
          5. Cardiogenic shock&#xD;
&#xD;
          6. Patients with special communication needs&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisa McAlindon, BMBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bristol</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>November 7, 2011</study_first_submitted>
  <study_first_submitted_qc>November 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2011</study_first_posted>
  <last_update_submitted>October 27, 2014</last_update_submitted>
  <last_update_submitted_qc>October 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bristol</investigator_affiliation>
    <investigator_full_name>Elisa McAlindon</investigator_full_name>
    <investigator_title>Cardiology Clinical Research Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

